Home / Industries / Healthcare

Healthcare

Research Reports in Healthcare

North America GLP-1 Receptor Agonist Market

North America GLP-1 Receptor Agonist Market (2026–2035)

North America GLP-1 Receptor Agonist Market was valued at USD 27.27 Billion in 2025 and is expected to reach USD 88.55 Billion by 2035, growing at a CAGR of 12.50% from 2026-2035.

Date: October 2026 | Report Code: SNS/HC/11385 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11385 | Pages: 300

Europe GLP-1 Receptor Agonist Market

Europe GLP-1 Receptor Agonist Market (2026–2035)

Europe GLP-1 Receptor Agonist Market was valued at USD 14.54 Billion in 2025 and is expected to reach USD 58.84 Billion by 2035, growing at a CAGR of 15.00% from 2026-2035.

Date: October 2026 | Report Code: SNS/HC/11384 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11384 | Pages: 300

Asia Pacific GLP-1 Receptor Agonist Market

Asia Pacific GLP-1 Receptor Agonist Market (2026–2035)

Asia Pacific GLP-1 Receptor Agonist Market was valued at USD 13.94 Billion in 2025 and is expected to reach USD 146.25 Billion by 2035, growing at a CAGR of 26.50% from 2026-2035.

Date: October 2026 | Report Code: SNS/HC/11383 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11383 | Pages: 300

Healthcare Satellite Connectivity Market

Healthcare Satellite Connectivity Market (2026-2035)

Global Healthcare Satellite Connectivity Market was valued at $9.35 Bn in 2025 and is expected to reach $17.89 Bn by 2035, grow at a CAGR of 6.72%. 

Date: October 2026 | Report Code: SNS/HC/11375 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11375 | Pages: 300

Cell Therapy Monitoring Kits Market

Cell Therapy Monitoring Kits Market (2026-2035)

Global Cell Therapy Monitoring Kits Market was valued at $2.26 Bn in 2025 and is expected to reach $4.35 Bn by 2035, growing at a CAGR of 6.81%.

Date: October 2026 | Report Code: SNS/HC/11374 | Pages: 350
Date: October 2026 | Report Code: SNS/HC/11374 | Pages: 350

Ketoanalogues For Kidney Diseases Market

Ketoanalogues For Kidney Diseases Market (2026-2035)

Global Ketoanalogues For Kidney Diseases Market was valued at $260.56 Bn in 2025 and is expected to reach $535.63 Bn by 2035, at a CAGR of 7.50%.

Date: October 2026 | Report Code: SNS/HC/11373 | Pages: 350
Date: October 2026 | Report Code: SNS/HC/11373 | Pages: 350

Cardiorenal Nutrition Products Market

Cardiorenal Nutrition Products Market (2026-2035)

Global Cardiorenal Nutrition Products Market was valued at $142.60 Mn in 2025 and is expected to reach $324.24 Mn by 2035, grow at a CAGR of 8.58%.

Date: October 2026 | Report Code: SNS/HC/11372 | Pages: 350
Date: October 2026 | Report Code: SNS/HC/11372 | Pages: 350

Asia Pacific Longevity Market

Asia Pacific Longevity Market (2026–2035)

Asia Pacific: Asia Pacific Longevity Market was USD 6.63 Billion in 2025, expected to reach USD 19.24 Billion by 2035, at 11.25% CAGR from 2026 to 2035.

Date: October 2026 | Report Code: SNS/HC/11371 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11371 | Pages: 300

U.S. Longevity Market

U.S. Longevity Market (2026–2035)

U.S. Longevity Market was USD 9.16 Billion in 2025, expected to reach USD 20.17 Billion by 2035, at 8.34% CAGR from 2026 to 2035.

Date: October 2026 | Report Code: SNS/HC/11370 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11370 | Pages: 300

North America Longevity Market

North America Longevity Market (2026–2035)

North America Longevity Market was valued at USD 11.00 Billion in 2025 and is expected to reach USD 25.10 Billion by 2035, growing at a CAGR of 8.60% from 2026-2035.

Date: October 2026 | Report Code: SNS/HC/11363 | Pages: 300
Date: October 2026 | Report Code: SNS/HC/11363 | Pages: 300